tapebrief
DD · Q2 2025

DD · Q3 2025 Earnings

Cautious

DuPont

Reported November 6, 2025

30-second summary

Standalone DuPont posted $3.07B revenue (+7% YoY, +6% organic) and $1.09 non-GAAP EPS, exceeding prior Q3 guidance on a Total DuPont basis, with operating EBITDA margin at 27.3% and FY2025 EBITDA guide raised from $1.575B to $1.600B (current-perimeter); pro forma FY EBITDA was revised from $1.62B to $1.63B and pro forma adjusted EPS from $2.00 to $2.02. Management was explicit that Q3 organic growth was inflated by customers pulling October orders forward into Q3 ahead of the Qnity separation blackout — the Q4 guide of $1.685B sales / $385M EBITDA / $0.43 EPS implies organic sales decline of ~1% reported (~+1% normalized), an abrupt deceleration from the Q3 headline. The bull-case beat sits next to a Q4 guide that, normalized, lands at ~1% organic — the trajectory matters more than the print.

Headline numbers

EPS

Q3 FY2025

$1.09

Revenue

Q3 FY2025

$3.07B

+7.0% YoY

Gross margin

Q3 FY2025

38.9%

Free cash flow

Q3 FY2025

$0.45B

Operating margin

Q3 FY2025

27.3%

Key financials

Q3 FY2025
MetricQ3 FY2025YoYQ2 FY2025QoQ
Revenue$3.07B+7.0%$3.26B-5.7%
EPS$1.09—$1.12-2.7%
Gross margin38.9%—37.3%+160bps
Operating margin27.3%—9.4%+1790bps
Free cash flow$0.45B—$0.27B+67.9%

Guidance

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

Actuals vs prior guidance

MetricPeriodPrior guideActualΔResult
RevenueQ3 FY2025$3.32 billion$3.072 billion-7.5% below guideBeat
Adjusted EPSQ3 FY2025$1.15$1.09-5.2% below guideBeat
Operating EBITDAQ3 FY2025$875 million$840 million-4.0% below guideBeat
Organic Sales GrowthQ3 FY2025approximately 3% year-over-year6%+3 percentage points above guideBeat

New guidance

MetricPeriodGuideYoY
Base Tax RateFY2025approximately 28%—
Net SalesQ4 FY2025$1.685 billion—
Operating EBITDAQ4 FY2025$385 million—
Adjusted EPSQ4 FY2025$0.43—
Organic Sales GrowthQ4 FY2025approximately 1% (normalized); approximately (1)% reported basis—

Changes to prior guidance

MetricPeriodPrior guideNew guideΔResult
Revenue
FY2025
$12.85 billion$6.84 billion-$6.01 billionLowered
Adjusted EPS
FY2025
$4.40$1.66-$2.74Lowered
Operating EBITDA
FY2025
$3,360 million$1,600 million-$1,760 millionLowered

Reaffirmed unchanged this quarter: Organic Sales Growth (up 2% year-over-year)

Segment KPIs

Q3 FY2025
SegmentQ3 FY2025YoY
IndustrialsCo$1.797B+5.0%
ElectronicsCo$1.275B+11.0%

Other KPIs

Q3 FY2025
SegmentQ3 FY2025YoY
U.S. & Canada$1.063B+7.0%
EMEA$0.49B+11.0%
Asia Pacific$1.423B+6.0%
Latin America$0.096B+7.0%
Operating EBITDA$840 million—
Operating EBITDA Margin27.3%—
Organic Sales Growth6%—
IndustrialsCo Operating EBITDA Margin25.9%—
ElectronicsCo Operating EBITDA Margin31.6%—
Transaction-Adjusted Free Cash Flow$576 million—
Transaction-Adjusted FCF Conversion126%—
Quarterly Dividend$0.20 per share—

Management tone

Q2 anchor → Q3 anchor: "Spin execution and tariff hedging" → "Post-separation offensive posture with operational governance"

The defensive posture from Q2 has flipped to offense. Last quarter management leaned heavily on tariff mitigation, AFFF settlement framing, and currency offsets to hold the topline guide. This quarter, with the spin closed, the framing shifted entirely to operational momentum and capital deployment. The quote that anchors this: "Our stronger underlying performance translates into revised full year 2025 pro forma estimates for operating EBITDA of $1.63 billion and adjusted EPS of $2.02 per share compared to the $1.62 billion and $2 per share." The change in tone reflects the removal of separation execution risk, not a step-change in operating fundamentals — but the willingness to commit to medium-term targets (2026-2028) publicly is new.

The "AI-driven concentration" admission from Q2 has been replaced by silence on electronics mix. Last quarter Kemp said all the growth for several quarters came from AI applications, with "most of the rest of the electronics economy" weak. This quarter, with ElectronicsCo now separating, that disclosure is gone — the standalone DuPont story is about healthcare, water, and shelter, not AI. This is a deliberate narrative reset, and the +11% ElectronicsCo print is the last time it's a DuPont talking point.

Construction weakness has gone from "embedded in the plan" to "the negative offset that's smaller than the positives." Management's framing — "We expect organic sales to be up 2% year over year on strong demand in healthcare and water, partially offset by ongoing weakness in construction and markets" — relegates shelter to a footnote. The Q&A revealed shelter is down ~4% full year and ~1% in H2; normalization to flat would be a material 2026 lift. The shift from headline risk to background drag is significant.

Operational governance gained quantified specificity. Q2 had generic references to business systems; this quarter management introduced 8 core KPIs (4 financial, 2 customer, 2 employee), named a new ops leader (Dave Cook ex-Danaher) and an 80-20 deployment lead (Beth Ferreira ex-ITW), and noted lower corporate costs are accelerating toward the previously communicated $95M public-company corporate cost run-rate. "We have designed a more transparent, data-driven process, which links demand generation, opportunity qualification, and conversion metrics." This is the language of a company building durable internal controls, not just rolling out a slogan.

A new strategic intent surfaced: explicit portfolio mix shift target. In response to the J.P. Morgan question, management disclosed for the first time a target portfolio mix of ~67% healthcare+water / ~33% diversified, vs. current 50/50. This is a meaningful divestiture signal that wasn't in Q2's commentary.

Recurring themes management leaned on this quarter:

AI-driven demand acceleration in interconnect solutions and semiconductor technologiesDisciplined capital allocation with dividend and $2B share repurchase authorizationOperational excellence and business system embedding driving margin expansionHealthcare and water secular tailwinds offsetting construction weaknessPortfolio simplification post-separation enabling focused executionPipeline discipline and commercial excellence framework rollout

Risks management surfaced:

Ongoing weakness in construction marketsUnfavorable mix headwinds in Electronics Co.Currency headwinds (basis points noted but manageable)Growth investments offsetting productivity gains in near termTax rate headwinds from interest expense allocation (200 bps noted)

Q&A highlights

Jeff Sprague · Vertical Research Partners

Asked about timing benefit from separation and whether it was customer-driven or company-initiated; also sought insights on 2026 exit rates and pluses/minuses for healthcare, water, and shelter businesses.

Management clarified the timing benefit was entirely customer-driven, as customers accelerated October orders into Q3 due to separation blackout period. No changes to organic growth expectations. Healthcare and water expected to deliver ~5% organic growth (medium-term targets). Shelter down ~1% in H2 but ~4% full year; normalization to flat would provide material lift into 2026.

Q3 organic growth pulled forward due to customer acceleration during blackout periodHealthcare and water exiting at 5% organic growth, in line with medium-term targetsShelter down ~1% in H2, ~4% full year; normalization to flat would materially improve 2026Diversified side at 2% in second half, in line with full year

Scott Davis · Familius Research

Inquired about balance sheet strategy, leverage targets, capital allocation priorities including M&A and buybacks, and details on lean/operational excellence initiatives with new COO hire.

Pro forma net debt/EBITDA at 1.7x with target below 2x; $3.25B pro forma debt, $1B cash. $2B buyback authorization with $500M ASR imminent. ~$500M/year of deployable FCF over three years. Dave Cook hired from Danaher to drive OpEx; rolling out enhanced management standards, 8 core KPIs (4 financial, 2 customer, 2 employee). RO capacity acquired in China for local-for-local positioning. Pipeline rich in healthcare CDMO and water opportunities.

Pro forma net debt to EBITDA: 1.7x, target below 2xPro forma debt: $3.25B, pro forma cash: $1B$2B share repurchase authorization, ~$500M ASR imminent~$500M/year deployable FCF over next 3 years

Steve Tusa · J.P. Morgan

Asked about 80-20 initiatives and portfolio pruning opportunities, particularly interest in shifting mix toward secular growth markets.

Beth Ferreira (ex-ITW) brought in to deploy 80-20 framework across diversified industrial businesses. Current portfolio mix is 50/50 healthcare+water vs. diversified; goal is to shift toward two-thirds/one-third mix to get more secular growth exposure. No specific businesses identified for pruning but clear stated objective to reduce cyclical exposure.

Beth Ferreira (ex-ITW) hired to deploy 80-20 frameworkCurrent portfolio: 50% healthcare+water, 50% diversifiedTarget portfolio: ~67% healthcare+water, ~33% diversifiedGoal to shift toward more secular-based end markets

John McCulty · BMO Capital Markets

Asked where the pro forma EBITDA guidance raise is coming from (volume vs. margin/efficiency) and sought color on M&A pipeline depth.

Margin expansion rather than volume; driven by better operational performance and segment performance this year flowing through. M&A pipeline is robust, deeper on healthcare due to fragmentation, shallower on water due to consolidation. Most targets are PE-owned on both sides, enabling transactions vs. strategic pries. Looking at opportunities in CDMO, med packaging, and water filtration beyond traditional industrial wastewater/desalination.

Guidance raise driven by margin/operational performance improvements, not volumeHealthcare M&A pipeline: deeper due to fragmentationWater M&A pipeline: shallower due to consolidationMajority of targets PE-owned, enabling transaction opportunities

Chris Parkinson · Wolf Research

Asked what the street is missing about the independent company's outlook and what management is most enthusiastic about post-separation; also queried strategy for expanding beyond water filtration (e.g., metering).

Street is confused on valuation due to pre-market trading noise and Aramids separation; management sees this as temporary. Longer-term, street underestimates transformation from chemical company to multi-industrial with mid-single-digit growth profile. New DuPont has simplified, streamlined portfolio and refreshed leadership team. On water strategy: actively pursuing systems plays and other filtration opportunities (food/beverage, microelectronics, dairy); metering valuations too high, not pursuing that.

Beat and raise in Q3; New DuPont also raised guidancePortfolio transformed to multi-industrial vs. chemical company perceptionPursuing systems plays and expanded filtration beyond industrial wastewater/desalinationNot pursuing metering due to high valuations

Answers to last quarter's watch list

ElectronicsCo growth holding above mid-single-digits as China hyperscaler demand normalizes — ElectronicsCo posted +11% in Q3. However, ElectronicsCo separated on November 1 and is no longer part of DuPont, rendering the watch item moot going forward.
Not resolved
Lagging-edge semiconductor recovery confirmation — Not addressed on the standalone DuPont call given ElectronicsCo separation.
Not resolved
IndustrialsCo organic growth turning positive on volume — IndustrialsCo printed +5% reported / +4% organic in Q3, but ~$30M of that came from October orders pulled forward; ex-timing, organic growth was +2%, and the Q4 guide implies ~+1% normalized — consistent with the +2% full-year diversified run-rate.
Continue monitoring
Tariff guidance revision — Tariffs were not flagged as a material driver this quarter; the narrative shifted to operational execution and portfolio. Management didn't quantify a revised tariff impact on the print.
Not resolved
September 18 Investor Day — capital allocation frameworks — Delivered: $2B buyback authorization, <2x net leverage target, ~$500M/year deployable FCF, M&A focus on healthcare CDMO/med packaging and water filtration adjacencies.
Resolved positively
Confirmation of November 1 spin completion — Confirmed completed; Qnity (ElectronicsCo) now separate.
Resolved positively

What to watch into next quarter

Whether Q4 organic sales decline of ~1% reported (~+1% normalized) holds or worsens — the timing pull-forward should reverse cleanly; any larger decline signals genuine end-market deterioration beyond the optical reversal.

Q4 operating EBITDA margin landing near the implied ~22.8% — a 450bps sequential step-down from Q3's 27.3% needs to be entirely seasonality/mix; any miss against the $385M guide raises questions about the structural margin run-rate.

First disclosed divestiture or M&A action toward the 67/33 healthcare+water target — management committed publicly to the mix shift; investors will watch for the first concrete transaction within 2-3 quarters.

ASR execution and timing of the remaining $1.5B of the $2B buyback authorization — the ~$500M ASR was flagged as imminent; pace of the remainder signals capital allocation discipline against M&A pipeline.

Shelter/construction stabilization signal — management framed shelter normalization to flat (from -4%) as a material 2026 catalyst; the Q4 print and early-2026 commentary on this segment is the cleanest read on 2026 base-rate growth.

Sources

  1. DuPont Q3 2025 Earnings Press Release / Schedules (8-K Ex. 99.1), filed November 6, 2025: https://www.sec.gov/Archives/edgar/data/1666700/000166670025000058/exhibit991enrschedules-3q25.htm
  2. DuPont Q3 2025 Earnings Conference Call (transcript-sourced commentary as available).

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.